Evolent Health, Inc EVH
3.61
0.09
2.56%
as of 25 Sep
- Market cap
- $398.0M
- P/E
- 0.0×
Follow EVH
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.64 | 1.89 | 2.46 | 1.08 | 1.47 | 2.62 | 1.87 | 1.89 | 0.51 | 0.24 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 173.02 | 0.00 | 32.52 | 0.00 | 96.07 |
P/Operating CF |
(31.20) | 136.49 | (61.79) | 56.52 | (105.94) | 35.73 | 70.82 | 41.42 | (49.18) | 9.36 |
P/B ratio |
0.74 | 0.79 | 1.30 | 0.80 | 2.20 | 3.43 | 2.94 | 3.47 | 1.29 | 1.10 |
Price to Tangible BV |
25.20 | 4.66 | 17.90 | 15.36 | 244.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.27 | 1.48 | 2.20 | 1.33 | 1.40 | 2.48 | 2.03 | 2.08 | 0.63 | 0.67 |
EV/EBITDA |
0.00 | 0.00 | 629.71 | 0.00 | 25.98 | 46.30 | 28.47 | 61.12 | 18.75 | 10.56 |
EV/Operating CF |
(16.27) | (23.04) | (66.87) | (21.48) | (79.59) | 58.20 | (237.02) | 28.71 | 86.18 | 32.16 |
EV/FCF |
(11.32) | (11.54) | (22.94) | (11.72) | (28.26) | 163.85 | (54.86) | 35.95 | (263.90) | 262.75 |
Quick Ratio |
1.92 | 2.64 | 1.72 | 1.03 | 1.13 | 1.06 | 1.06 | 0.97 | 0.81 | 1.27 |
Current Ratio |
2.01 | 2.85 | 1.81 | 1.19 | 1.36 | 1.18 | 1.10 | 1.01 | 0.85 | 1.31 |
Net Debt/EBITDA |
1.56 | 4.54 | (73.87) | (5.16) | (1.41) | (2.59) | 2.19 | 5.83 | 3.79 | 6.70 |
Debt/Assets |
10.02% | 9.25% | 12.83% | 19.60% | 19.20% | 15.19% | 22.73% | 22.28% | 19.28% | 51.10% |
Debt/Equity |
0.13 | 0.12 | 0.19 | 0.32 | 0.43 | 0.31 | 0.48 | 0.48 | 0.41 | 2.34 |
Asset Turnover |
0.23 | 0.35 | 0.41 | 0.43 | 0.64 | 0.65 | 0.84 | 0.87 | 0.98 | 0.84 |
Operating CF/Net income |
0.22 | 0.46 | 0.39 | 0.14 | 0.05 | (1.03) | 0.60 | (1.00) | (0.20) | (0.07) |
Capex/Depreciation |
(0.09) | (0.84) | (0.80) | (0.13) | (0.09) | (0.27) | (0.41) | (0.21) | (0.20) | (0.06) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (17.30%) | (6.20%) | (4.71%) | (28.51%) | (43.17%) | (5.73%) | (2.47%) | (14.76%) | (9.03%) | (81.81%) | |
| (14.42%) | (4.83%) | (3.47%) | (18.75%) | (23.29%) | (2.69%) | (1.18%) | (6.33%) | (3.58%) | (26.08%) | |
ROIC |
(18.12%) | (5.25%) | (2.89%) | (17.55%) | (29.89%) | (4.67%) | 0.21% | (2.72%) | (1.67%) | (21.22%) |
Return on Tangible Assets |
(97.28%) | (20.47%) | (18.02%) | (249.18%) | (144.95%) | (23.53%) | (14.46%) | (162.35%) | 265.25% | (286.98%) |
Average Days of Receivables |
58.35 | 41.08 | 46.69 | 40.19 | 48.97 | 52.50 | 68.76 | 83.03 | 59.25 | 60.28 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
63.22% | 47.29% | 37.54% | 34.41% | 22.76% | 24.18% | 19.92% | 18.23% | 10.30% | 16.20% |
Intangible Assets out of Total Assets |
0.74 | 0.66 | 0.64 | 0.59 | 0.45 | 0.50 | 0.64 | 0.70 | 0.71 | 0.67 |
Share Based Compensation of Revenue |
8.85% | 4.70% | 2.81% | 2.27% | 1.58% | 1.84% | 2.51% | 2.06% | 1.56% | 2.12% |
Graham Net Nets |
(0.03) | 0.14 | (0.03) | (0.46) | (0.15) | (0.08) | (0.19) | (0.20) | (0.58) | (2.14) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(24.83%) | (7.66%) | (3.41%) | (40.11%) | (24.39%) | (1.59%) | (0.74%) | (3.82%) | (7.29%) | (128.75%) |
Free Cash Flow Yield |
(7.61%) | (6.78%) | (3.90%) | (10.49%) | (3.36%) | 0.58% | (1.97%) | 3.07% | (0.47%) | 1.04% |
Revenue per Share |
5.64 | 6.76 | 8.11 | 8.34 | 10.89 | 10.55 | 14.43 | 17.65 | 22.28 | 16.43 |
Operating CF per Share |
(0.79) | (0.43) | (0.27) | (0.52) | (0.19) | 0.45 | (0.12) | 1.28 | 0.16 | 0.34 |
Capex per Share |
(0.34) | (0.43) | (0.51) | (0.43) | (0.35) | (0.29) | (0.41) | (0.26) | (0.22) | (0.30) |
Free Cash Flow per Share |
(1.13) | (0.87) | (0.78) | (0.95) | (0.54) | 0.16 | (0.53) | 1.02 | (0.05) | 0.04 |
Cash per Share |
4.74 | 4.67 | 4.95 | 1.49 | 3.93 | 3.97 | 2.16 | 1.86 | 1.43 | 1.56 |
Shareholders Equity per Share |
20.26 | 16.26 | 15.38 | 11.28 | 7.30 | 8.06 | 9.17 | 11.20 | 10.39 | 3.64 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
20.26 | 16.26 | 15.38 | 11.28 | 7.30 | 8.06 | 9.17 | 11.20 | 10.39 | 3.64 |
Free Cash Flow |
(51.04) | (55.81) | (60.20) | (78.18) | (45.70) | 13.76 | (49.91) | 113.84 | (6.13) | 4.76 |
Working Capital |
133.03 | 245.48 | 218.61 | 36.03 | 144.36 | 78.47 | 44.61 | 9.43 | (108.38) | 121.11 |
Capital Expenditures |
(15.53) | (27.85) | (39.55) | (35.53) | (29.47) | (24.98) | (38.36) | (28.74) | (24.89) | (34.09) |
Net Current Asset Value |
(22.76) | 111.79 | (44.96) | (340.17) | (204.45) | (201.86) | (479.82) | (750.51) | (745.86) | (977.67) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 751.87 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.02 |
Net Profit Margin |
(62.84%) | (13.95%) | (8.40%) | (43.95%) | (36.15%) | (4.14%) | (1.42%) | (7.24%) | (3.66%) | (30.88%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 694.12 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.70 | 0.65 | 0.67 | 3.24 | 3.62 | 1.12 | 1.05 | 1.77 | 1.73 | 6.54 |
Cash ROIC |
(5.35%) | (5.37%) | (5.26%) | (9.50%) | (8.42%) | (3.41%) | (6.74%) | 3.14% | (2.95%) | (2.68%) |
Accounts Receivable Turnover |
8.33 | 9.71 | 9.71 | 8.82 | 9.26 | 7.13 | 7.02 | 5.60 | 5.93 | 5.18 |
Accounts Payable Turnover |
5.12 | 6.20 | 3.46 | 5.57 | 20.06 | 10.27 | 13.51 | 28.52 | 30.32 | 18.95 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
103.24 | 58.17 | 163.40 | 26.67 | 16.75 | 53.34 | 20.15 | 11.71 | 16.02 | 14.78 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
30.51 | 44.79 | 64.58 | 77.94 | 99.87 | 127.33 | 192.64 | 350.72 | 430.72 | 362.27 |
Average Payables |
30.30 | 43.41 | 94.85 | 92.12 | 34.73 | 64.03 | 76.63 | 52.71 | 72.14 | 77.90 |
Average Assets |
1,107.68 | 1,256.27 | 1,517.49 | 1,610.15 | 1,434.86 | 1,395.58 | 1,618.38 | 2,248.80 | 2,612.36 | 2,221.82 |
Average Common Equity |
923.35 | 979.21 | 1,117.83 | 1,059.20 | 774.32 | 656.62 | 776.53 | 963.56 | 1,034.48 | 708.23 |
Columns are period end dates